Lipid Nanoparticles

Abstract KRAS G12S mutations in non-small cell lung cancer (NSCLC) remain refractory to current targeted therapies, with few clinical options and...

Abstract Liposomes have gained a great attention in cosmeceutical dermal delivery. These nanolipid carriers can load numerous actives, and when...

Abstract Background: An efficient formulation of lipid nanoparticles (LNPs) is often considered crucial in the successful development of nucleic acid...

Abstract Berberine, known as an antioxidant agent, can improve glycemic indices in animal models of diabetes; however, it is clinically...

Abstract The development of safer treatment alternatives for cancer and other chronic illnesses still calls for innovation. Chemopreventive agents (e.g.,...

Abstract Background/Objectives: The growing threat posed by antimicrobial resistance to worldwide public health highlights the urgent need not only for new...

Abstract Lipid-based drug delivery carriers have exhibited substantial potential for promoting wound healing. Here, Phospholipon® 90H (P90H) based lipid nanoparticles...

Abstract Small interfering RNA (siRNA)-loaded lipid nanoparticles (LNPs) are a promising modality for gene silencing therapies. Pulmonary delivery offers an...

Abstract The present study aimed to design, optimize, and evaluate enteric-coated nanocarriers to enhance the oral bioavailability of Rifaximin, a...

Abstract Solid lipid nanoparticles (SLNs) exhibit excellent potential as a drug delivery system in treating several cancers including gastrointestinal (GI)...